ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

510
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
bullishLG CNS
08 Dec 2023 07:21

2024 Major IPOs Pipeline in Korea

This insight will feature 50 of the biggest potential IPOs in Korea in 2024. This is our 9th "Annual Edition of the Major Korean IPOs Pipeline...

Logo
835 Views
Share
bearishOrigin Energy
04 Dec 2023 00:11

Merger Arb Mondays (4 Dec) - Origin, OreCorp, Healius, CIMC Vehicles, T&K Toka, Eoflow, Hollysys

This week, the highest gross spreads are Eoflow (215.5%), 111 (93.7%), IRC (22.9%), OreCorp (20.8%), Healius (18.7%), Hollysys (15.5%), Origin...

Logo
1.1k Views
Share
01 Dec 2023 08:51

(Mostly) Asia M&A, Nov 2023: Taisho Pharma, CIMC Vehicle, CMIC, Japan Best Rescue, Shidax

For the month of November, 16 new deals were discussed on Smartkarma with an overall deal size of ~US$13bn. The average premium for the new deals...

Logo
495 Views
Share
29 Nov 2023 13:39

Spread Trade Opportunities Arising from KQ150/KS200 Passive Flows in the Celltrion Merger

This post delves into the detailed implications of the Celltrion merger on KOSPI 200/KOSDAQ 150 passive flows. It's crucial, as the widening swap...

Logo
506 Views
Share
bearishOrigin Energy
27 Nov 2023 00:18

Merger Arb Mondays (27 Nov) - Origin, OreCorp, Healius, Taisho, JSR, Eoflow, Hollysys, Haitong Intl

This week, the highest gross spreads are Eoflow (218%), 111 (69.4%), Taisho Pharma (55.5%), Healius (48.0%), IRC (20.4%), Hollysys (12.8%), Origin...

Logo
592 Views
Share
x